Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 38708-38709 [2017-17161]

Download as PDF 38708 Federal Register / Vol. 82, No. 156 / Tuesday, August 15, 2017 / Notices contract personnel, solely for cybersecurity purposes. All contract personnel will sign appropriate nondisclosure agreements. Authority: These investigations are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.12 of the Commission’s rules. By order of the Commission. Issued: August 9, 2017. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2017–17177 Filed 8–14–17; 8:45 am] BILLING CODE 7020–02–P 12, 2017 (82 FR 17691). The hearing was held in Washington, DC, on June 13, 2017, and all persons who requested the opportunity were permitted to appear in person or by counsel. The Commission made this determination pursuant to section 735(b) of the Act (19 U.S.C. 1673d(b)). It completed and filed its determination in this investigation on August 9, 2017. The views of the Commission are contained in USITC Publication 4713 (August 2017), entitled Dioctyl Terephthalate (DOTP) from Korea: Investigation No. 731–TA–1330 (Final). By order of the Commission. Issued: August 9, 2017. Lisa R. Barton, Secretary to the Commission. INTERNATIONAL TRADE COMMISSION [Investigation No. 731–TA–1330 (Final)] [FR Doc. 2017–17178 Filed 8–14–17; 8:45 am] Dioctyl Terephthalate (DOTP) From Korea; Determination BILLING CODE 7020–02–P mstockstill on DSK30JT082PROD with NOTICES On the basis of the record 1 developed in the subject investigation, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that an industry in the United States is materially injured by reason of imports of dioctyl terephthalate (‘‘DOTP’’) from Korea, provided for in subheading 2917.39.20 of the Harmonized Tariff Schedule of the United States, that have been found by the Department of Commerce (‘‘Commerce’’) to be sold in the United States at less than fair value (‘‘LTFV’’).2 Background The Commission, pursuant to section 735(b) of the Act (19 U.S.C. 1673d(b)), instituted this investigation effective June 30, 2016, following receipt of a petition filed with the Commission and Commerce by Eastman Chemical Company, Kingsport, Tennessee. The Commission scheduled the final phase of the investigation following notification of a preliminary determination by Commerce that imports of DOTP from Korea were being sold at LTFV within the meaning of section 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the Commission’s investigation and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of April 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). 2 Vice Chairman David S. Johanson dissenting. VerDate Sep<11>2014 17:15 Aug 14, 2017 Jkt 241001 JUDICIAL CONFERENCE OF THE UNITED STATES Meeting of the Judicial Conference Advisory; Committee on Rules of Criminal Procedure Judicial Conference of the United States, Advisory Committee on Rules of Criminal Procedure. AGENCY: ACTION: Notice of open meeting. The Advisory Committee on Rules of Criminal Procedure will hold a meeting on October 24, 2017. The meeting will be open to public observation but not participation. An agenda and supporting materials will be posted at least 7 days in advance of the meeting at: http://www.uscourts.gov/ rules-policies/records-and-archivesrules-committees/agenda-books. SUMMARY: DATES: TIME: October 24, 2017. 9:00 a.m. to 5:00 p.m. United States District Court for Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Chicago, IL 60604. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Rebecca A. Womeldorf, Rules Committee Secretary, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. Dated: August 8, 2017. Rebecca A. Womeldorf, Rules Committee Secretary. [FR Doc. 2017–17147 Filed 8–14–17; 8:45 am] BILLING CODE 2210–55–P PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical Technology Enterprise Consortium Notice is hereby given that, on June 23, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical Technology Enterprise Consortium (‘‘MTEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Appili Theraputics, Inc., Halifax, Nova Scotia, CANADA; BioTime, Inc., Alameda, CA; Chenega Healthcare Services, LLC, San Antonio, TX; Critical Innovations LLC, Venice, CA; Embody LLC, Norfolk, VA; Kansas State University, Manhattan, KS; NovaHep AB, Gothenburg, SWEDEN; Pulmotect, Inc., Houston, TX; QBiotics Limited, Taringa, Queensland, AUSTRALIA; SIMETRI, Inc., Winter Park, FL; SpherIngenics, Inc., Richmond, VA; Spherium Biomed SL, Barcelona, SPAIN; Techulon, Inc., Blacksburg, VA; The Trustees of Columbia University in the City of New York, New York, NY; The University of Texas Health Science Center at Houston, Houston, TX; UT Health San Antonio, San Antonio, TX; and Vapogenix, Inc., Houston, TX, have been added as parties to this venture. Also, MedPro Technologies, Inc., San Antonio, TX; MetArmor, Inc., Glen Gardner, NJ; Michigan Technological University, Houghton, MI; and Organovo, Inc., San Diego, CA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MTEC intends to file additional written notifications disclosing all changes in membership. On May 9, 2014, MTEC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2014 (79 FR 32999). The last notification was filed with the Department on April 19, 2017. A notice was published in the Federal E:\FR\FM\15AUN1.SGM 15AUN1 Federal Register / Vol. 82, No. 156 / Tuesday, August 15, 2017 / Notices Register pursuant to Section 6(b) of the Act on May 2, 2017 (82 FR 20488). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017–17161 Filed 8–14–17; 8:45 am] [FR Doc. 2017–17160 Filed 8–14–17; 8:45 am] BILLING CODE P BILLING CODE P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical CBRN Defense Consortium mstockstill on DSK30JT082PROD with NOTICES Register pursuant to Section 6(b) of the Act on May 12, 2017 (82 FR 22159). Notice Pursuant to the National Cooperative Research and Production Act of 1993—Digital Manufacturing Design Innovation Institute Notice is hereby given that, on July 12, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Countervail Corporation, Charlotte, NC; GenArraytion, Inc., Rockville, MD; Prosolia, Inc., Indianapolis, IN; Meso Scale Diagnostics, LLC, Rockville, MD; BioFire Defense, LLC, Salt Lake City, UT; Achaogen, Inc., San Francisco, CA; EpiVax, Inc., Providence, RI; CritiTech Particle Engineering Solutions LLC, Lawrence, KS; Colorado State University, Fort Collins, CO; Auburn University, Auburn, AL; BioCryst Pharmaceuticals, Inc., Durham, NC; and Medigen, Inc., Frederick, MD, have been added as parties to this venture. Also, Ibis BioSciences Inc., an Abbot Company, Carlsbad, CA, has withdrawn as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on April 10, 2017. A notice was published in the Federal Notice is hereby given that, on June 26, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), the Digital Manufacturing Design Innovation Institute (‘‘DMDII’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, the following parties have been added as members to this venture: Lawrence Technological University, Southfield, MI; University of North Carolina at Charlotte, Charlotte, NC; AMI Global, Las Vegas, NV; Amper Technologies, Evanston, IL; Autodesk, San Rafael, CA; C-Labs Corporation, Bellevue, WA; Connected Global Factory (SearchLight), Ann Arbor, MI; Dozuki, San Luis Obispo, CA; Egineering, Indianapolis, IN; Godwin Global, Charlotte, NC; NarrativeWave, Irvine, CA; Omative, Cincinnati, OH; Quality Tools & Abrasives Inc., Elk Grove Village, IL; SensrTrx, St. Louis, MO; Tulip, Milwaukee, WI; TYGES International, Williamsburg, VA; Universal Technical Resources, Cherry Hill, NJ; Verena Solutions LLC, Chicago, IL; and Warwick Analytics, Los Altos, CA, have been added as parties to this venture. Also, VTOL, Oak Lawn, IL; Affinegy, Inc., Austin, TX; Allied Plastics, Twin Lakes, WI; RECON Services, East Berlin, PA; Bi-Link, Bloomingdale, IN; Graphicast, Jaffrey, NH; Cummins, Columbus, IN; UL LLC, Chicago, IL; Steel Founders Society of America (SFSA), Crystal Lake, IL; McMaster Carr Supply Chain Company, Elmhurst, IL; Pella Corporation, Pella, IA; ABB, Inc, Bloomfield, CT; Moog, East Aurora, NY; BAE Systems Land & Armaments, L.P. York, PA; Teradyne, North Reading, VerDate Sep<11>2014 17:15 Aug 14, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 38709 MA; Westinghouse Electric Company, Cranberry Township, PA; University of Delaware, Newark, DE; and University of Louisville, Louisville, KY, have withdrawn as a parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and DMDII intends to file additional written notifications disclosing all changes in membership. On January 5, 2016, DMDII filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 9, 2016 (81 FR 12525). The last notification was filed with the Department on January 31, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on March 16, 2017 (82 FR 14033). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017–17159 Filed 8–14–17; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—National Armaments Consortium Notice is hereby given that, on July 13, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), National Armaments Consortium (‘‘NAC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, 3D Systems, Inc., Rock Hill, SC; ACTA, Inc., Torrance, CA; Advanced Hydrogen Technologies Corporation, Lenoir, NC; American Plastic Cartridge and Shell, LLC, Philadelphia, PA; Applied Physical Sciences Corp., Groton, CT; APT Research, Inc., Huntsville, AL; Arco Global Services Corp., Ft. Lauderdale, FL; Arete Associates, Huntsville, AL; Avatar Partners, Inc., Huntington Beach, CA; Boston Engineering Corporation, Waltham, MA; BrockTek, LLC, Sierra Vista, AZ; C6I Services Corporation, Chesterfield, NJ; Camco One Industries, E:\FR\FM\15AUN1.SGM 15AUN1

Agencies

[Federal Register Volume 82, Number 156 (Tuesday, August 15, 2017)]
[Notices]
[Pages 38708-38709]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17161]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on June 23, 2017, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise 
Consortium (``MTEC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Appili Theraputics, Inc., Halifax, Nova Scotia, CANADA; 
BioTime, Inc., Alameda, CA; Chenega Healthcare Services, LLC, San 
Antonio, TX; Critical Innovations LLC, Venice, CA; Embody LLC, Norfolk, 
VA; Kansas State University, Manhattan, KS; NovaHep AB, Gothenburg, 
SWEDEN; Pulmotect, Inc., Houston, TX; QBiotics Limited, Taringa, 
Queensland, AUSTRALIA; SIMETRI, Inc., Winter Park, FL; SpherIngenics, 
Inc., Richmond, VA; Spherium Biomed SL, Barcelona, SPAIN; Techulon, 
Inc., Blacksburg, VA; The Trustees of Columbia University in the City 
of New York, New York, NY; The University of Texas Health Science 
Center at Houston, Houston, TX; UT Health San Antonio, San Antonio, TX; 
and Vapogenix, Inc., Houston, TX, have been added as parties to this 
venture.
    Also, MedPro Technologies, Inc., San Antonio, TX; MetArmor, Inc., 
Glen Gardner, NJ; Michigan Technological University, Houghton, MI; and 
Organovo, Inc., San Diego, CA, have withdrawn as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on April 19, 
2017. A notice was published in the Federal

[[Page 38709]]

Register pursuant to Section 6(b) of the Act on May 12, 2017 (82 FR 
22159).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-17161 Filed 8-14-17; 8:45 am]
 BILLING CODE P